Stockreport

PDS Biotechnology Initiates Novel Vaccine Development Programs For COVID-19 and Universal Influenza; Delay of PDS0101 VERSATILE-002 trial

PDS Biotechnology Corporation  (PDSB) 
Last pds biotechnology corporation earnings: 11/7 06:00 am Check Earnings Report
PDF Expanded infectious disease program to address current and potential pandemics builds on existing tuberculosis collaboration Initiation of Phase 2 VERSATILE-002 trial f [Read more]